Press & Media
Resources for journalists, analysts, and media professionals covering the life sciences industry.
About Ambrosia Ventures
Ambrosia Ventures provides data-driven deal intelligence for the life sciences industry. Our platform analyzes 2,600+ publicly disclosed biopharma licensing transactions to help biotechnology companies benchmark deal terms and identify optimal partners.
The Deal Calculator enables biotech executives, business development professionals, and investors to estimate upfront payments, milestone structures, and royalty rates based on real market data across therapeutic areas including oncology, neurology, immunology, and metabolic/obesity.
Key Facts
2,600+
Deals Analyzed
12
Therapeutic Areas
15+
Modalities Covered
2018-Present
Data Coverage
Data & Methodology
Data Sources
SEC filings (8-K, 10-K, 10-Q), company press releases, investor presentations, and verified industry databases. All financial terms are cross-referenced for accuracy.
Update Frequency
New deals are added within 48 hours of public disclosure. Historical data is continuously validated and enriched with additional context.
Benchmark Methodology
Estimates represent the 25th-75th percentile range of comparable transactions, filtered by modality, development phase, therapeutic area, and geographic territory.
Media Assets
Logo & Brand Assets
Download high-resolution logos and brand guidelines for media use.
Request Media KitPress Contact
For press inquiries, interview requests, or data citations, please contact:
info@ambrosiaventures.coCitation Guidelines
When citing Ambrosia Ventures data or analysis, please use the following format:
For custom data requests or exclusive analysis, please contact our press team.